-
Unlocking the Code of Neurodegeneration: Stowers Scientist Joins $28.6 Million Research Initiative
A New Frontier in Brain Health Neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, remain some of the most complex challenges in modern medicine. A significant new development has emerged from the Stowers Institute for Medical Research, where scientist Jeffrey J. Pleiss, Ph.D., has been selected to participate in a massive, multi-institutional research effort. The $28.6…
-
Clene’s Upcoming Presentation at the Emerging Growth Conference: What Investors Should Know
NASDAQ: $CLNN Clene Inc., a clinical-stage company focused on developing treatments that target neurodegeneration and inflammation, has announced its participation in a significant industry event. The company is scheduled to present at the Emerging Growth Conference, as detailed in their recent press release. The Significance of the Emerging Growth Conference The Emerging Growth Conference (EGC)…